Share on StockTwits

Amsurg Corp (NASDAQ:AMSG) released its earnings data on Thursday. The company reported $0.63 earnings per share for the quarter, meeting the analysts’ consensus estimate of $0.63, Analyst Ratings Net reports. The company had revenue of $281.10 million for the quarter, compared to the consensus estimate of $281.51 million. During the same quarter last year, the company posted $0.58 earnings per share. Amsurg Corp’s revenue was up 5.2% compared to the same quarter last year. Amsurg Corp updated its Q3 guidance to $0.63-0.65 EPS and its FY14 guidance to $2.61-2.66 EPS.

Amsurg Corp (NASDAQ:AMSG) traded down 2.05% on Thursday, hitting $47.76. 1,554,405 shares of the company’s stock traded hands. Amsurg Corp has a 52 week low of $36.55 and a 52 week high of $52.81. The stock’s 50-day moving average is $48.27 and its 200-day moving average is $45.40. The company has a market cap of $1.962 billion and a P/E ratio of 21.67.

A number of analysts have recently weighed in on AMSG shares. Analysts at Zacks reiterated a “neutral” rating on shares of Amsurg Corp in a research note on Friday, July 4th. They now have a $51.00 price target on the stock. On the ratings front, analysts at SunTrust upgraded shares of Amsurg Corp from a “neutral” rating to a “buy” rating in a research note on Friday, June 27th. They now have a $54.00 price target on the stock, up previously from $50.00. Finally, analysts at Robert W. Baird upgraded shares of Amsurg Corp from a “neutral” rating to an “outperform” rating in a research note on Friday, June 27th. They now have a $55.00 price target on the stock, up previously from $44.00. Four equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus price target of $52.75.

AmSurg Corp. is the owner and operator of short stay ambulatory surgery centers (NASDAQ:AMSG) in the United States.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.